HELE vs RARE · rev $1.79B vs rev $350.0M
Helen of Troy Ltd (HELE) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Helen of Troy Ltd (HELE) is a household & personal products company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported HELE revenue for 2026-02-28 was $1.79B. Net income was -$899.0M. Revenue was down 6.4% from 2025-02-28 to 2026-02-28. HELE currently screens at market cap $566.1M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
HELE currently screens at market cap $566.1M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the HELE and RARE stock pages for the full models.
Not investment advice.